BiotechTube

Remimazolam Tosilate for injection + Propofol Injection

Phase 2/3Recruiting
0 watching 0 views this week📈 Rising
65
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Operative Sedation of Pediatric

Conditions

Operative Sedation of Pediatric, Operative Sedation of Adolescent Patients

Trial Timeline

Jul 10, 2025 → May 1, 2026

NCT ID
NCT07036419

About Remimazolam Tosilate for injection + Propofol Injection

Remimazolam Tosilate for injection + Propofol Injection is a phase 2/3 stage product being developed by Jiangsu Hengrui Medicine for Operative Sedation of Pediatric. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07036419. Target conditions include Operative Sedation of Pediatric, Operative Sedation of Adolescent Patients.

Hype Score Breakdown

Clinical
22
Activity
15
Company
10
Novelty
7
Community
8

Clinical Trials (1)

NCT IDPhaseStatus
NCT07036419Phase 2/3Recruiting

Competing Products

20 competing products in Operative Sedation of Pediatric

See all competitors
ProductCompanyStageHype Score
PRF110- oily solution (Ropivacaine)PainReformPhase 2
44
PRF110PainReformPhase 2
44
pudexacianinium chlorideAstellas PharmaPhase 3
77
YM177 + etodolac + PlaceboAstellas PharmaPhase 3
77
pudexacianinium chlorideAstellas PharmaPhase 3
77
QutenzaAstellas PharmaPre-clinical
23
Naldemedine + PlaceboShionogiPhase 2
52
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVEisaiApproved
85
Lemborexant 5 mg + Control (placebo) groupEisaiPhase 2
52
Ondansetron + PalonosetronEisaiPhase 2
52
AQUAVAN (fospropofol disodium; GPI 15715 )EisaiPhase 2
52
ONO-1101Ono PharmaceuticalPhase 2
52
ONO-1101Ono PharmaceuticalPhase 2/3
65
Test naproxen sodium tablet + Commercial naproxen sodium tablet + Commercial naproxen sodium liquid gels capsule + Placebo tabletJohnson & JohnsonPhase 3
77
Test acetaminophen + Commercial acetaminophen + Commercial ibuprofen + PlaceboJohnson & JohnsonPhase 3
77
AcetaminophenJohnson & JohnsonPhase 2
52
acetaminophen Tablet + acetaminophen Caplet + ibuprofen Liquid-filled capsule + Placebo Tablet + Placebo Caplet + Placebo Liquid-filled capsuleJohnson & JohnsonPhase 3
77
Levofloxacin Ophthalmic + CefuroximeSanten PharmaceuticalPhase 1/2
41
Levofloxacin Ophthalmic Product + Moxifloxacin Ophthalmic SolutionSanten PharmaceuticalPhase 1/2
41
Bupivacaine Liposome Injection T preparation + Bupivacaine Liposome Injection R preparationJiangsu Hengrui MedicinePhase 1
33

Other Products from Jiangsu Hengrui Medicine

ApatinibApproved
85
Remimazolam TosilateApproved
85
Henagliflozin 10 mg daily + Metformin 1700 mg dailyApproved
85
ImrecoxibApproved
85
IvarmacitinibApproved
85